Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.
C. Kendall Stover(Telesis Corporation (United States)), Alan G. Barbour
Cited by 269
Related Papers
New use of BCG for recombinant vaccines
|Nature|1991|1.5k